Social Clips Last Week’s Top 3 Most Read Posts About Scleroderma Last Week’s Top 3 Most Read Posts About Scleroderma by admin | December 28, 2015 Share this article: Share article via email Copy article link Read the Articles Here: iBio’s Anti-Fibrotic Drug Therapy Aims to Block Disease Researchers Find New Small Molecule Capable of Triggering the Immune System Systemic Sclerosis Patients’ Intestinal Microbiome Found To Be Enriched by Inflammatory Bacteria Print This Page Tags anti-fibrotic drug, iBio, immune system, Inflammatory Bacteria, Intestinal Microbiome, molecule, most read, researchers, top 3
April 1, 2025 News by Andrea Lobo, PhD Study of CAR T-cell therapy rese-cel in scleroderma enrolling in US
March 25, 2025 News by Andrea Lobo, PhD Ofev effectiveness, safety seen over 3-year SENSCIS extension trial
March 18, 2025 News by Margarida Maia, PhD Phase 1 trial of CAR T-cell therapy likely to open soon to SSc patients
